Patents by Inventor Stephen Page
Stephen Page has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230310388Abstract: Provided herein are methods of treating or preventing a fungal colonisation or infection in a subject. The method includes administering a therapeutically effective amount of a compound, or a therapeutically acceptable salt thereof, to the subject, wherein the fungal colonisation or infection is caused by a fungal agent.Type: ApplicationFiled: April 23, 2021Publication date: October 5, 2023Inventors: Stephen Page, Adam McCluskey, Martine Keenan, Andrew Stevens, Sanjay Garg
-
Patent number: 11566012Abstract: The invention provides compounds of Formula (I), and their use in methods for treating or preventing a protozoan infection in a subject using a compound of Formula (I). The invention also provides the use of a compound of Formula (I) in the manufacture of a medicament for the treatment of a protozoan infection in a subject. The invention further provides a medical device when used in a method of treating or preventing a protozoan infection in a subject and to a medical device comprising the composition of the invention.Type: GrantFiled: September 30, 2020Date of Patent: January 31, 2023Assignee: Neoculi Pty LtdInventors: Stephen Page, Andrew Stevens, Adam McCluskey, Martine Keenan, Rebecca Abraham
-
Patent number: 11491105Abstract: The invention includes methods and compositions for treating mastitis in a subject. The method includes the step of administering, by intramammary delivery, a therapeutically effective amount of a polyether ionophore, or a therapeutically acceptable salt thereof, to the mammary gland of the subject.Type: GrantFiled: February 10, 2014Date of Patent: November 8, 2022Assignee: LUODA PHARMA LIMITEDInventors: Stephen Page, Sanjay Garg
-
Publication number: 20220202797Abstract: A method of treating and/or preventing gastric ulcers, said method comprising administering by injection a therapeutically effective amount of a composition comprising: c) a first agent selected from the group consisting of: a medium chain triglyceride and a long chain triglyceride; and d) a second agent comprising a proton pump inhibitor or pharmaceutically or veterinary acceptable salt, wherein the composition is adapted for sustained release of a therapeutically effective amount of the proton pump inhibitor to a subject in need thereof.Type: ApplicationFiled: March 16, 2022Publication date: June 30, 2022Inventors: Nicholas Bova, Sanjay Garg, Stephen Page
-
Patent number: 11357855Abstract: The invention relates to a liquid formulation comprising propylene glycol and an effective amount of an inodilator, an angiotensin converting enzyme inhibitor, or a combination of an inodilator and an angiotensin converting enzyme inhibitor and to use of the formulation for treating cardiac disease and/or hypertension.Type: GrantFiled: August 16, 2019Date of Patent: June 14, 2022Assignee: LUODA PHARMA LIMITEDInventors: Nicholas Bova, Stephen Page, Giuseppe Pippia
-
Patent number: 11318123Abstract: A method of treating and/or preventing gastric ulcers, said method comprising administering by injection a therapeutically effective amount of a composition comprising: c) a first agent selected from the group consisting of: a medium chain triglyceride and a long chain triglyceride; and d) a second agent comprising a proton pump inhibitor or pharmaceutically or veterinary acceptable salt, wherein the composition is adapted for sustained release of a therapeutically effective amount of the proton pump inhibitor to a subject in need thereof.Type: GrantFiled: December 8, 2016Date of Patent: May 3, 2022Assignee: LUODA PHARMA LIMITEDInventors: Nicholas Bova, Sanjay Garg, Stephen Page
-
Patent number: 11293682Abstract: Methods and apparatuses for transferring heat to and from multiple objects. Such a method entails placing objects in a vessel that contains a heat transfer fluid so that the objects contact the heat transfer fluid. The heat transfer fluid is at a temperature that is different from the temperature of the object, and is induced to circulate along a continuous flowpath. Each object is at least partially disposed in the flowpath of the heat transfer fluid, and each object is individually rotated about an axis of rotation thereof. The heat transfer fluid continues to circulate and the objects continue to rotate for a time sufficient to cause the temperatures of the objects to become closer to the heat transfer fluid temperature.Type: GrantFiled: April 26, 2019Date of Patent: April 5, 2022Assignee: Purdue Research FoundationInventors: Mitchell Anthony LoVerde, David Stephen Page, Kyle Chang Ma, Scott Robert Lancaster, Christopher James Mead
-
Publication number: 20210009552Abstract: The invention provides compounds of Formula (I), and their use in methods for treating or preventing a protozoan infection in a subject using a compound of Formula (I). The invention also provides the use of a compound of Formula (I) in the manufacture of a medicament for the treatment of a protozoan infection in a subject. The invention further provides a medical device when used in a method of treating or preventing a protozoan infection in a subject and to a medical device comprising the composition of the invention.Type: ApplicationFiled: September 30, 2020Publication date: January 14, 2021Inventors: Stephen Page, Andrew Stevens, Adam McCluskey, Martine Keenan, Rebecca Abraham
-
Patent number: 10829468Abstract: The invention provides compounds of Formula (I), and their use in methods for treating or preventing a protozoan infection in a subject using a compound of Formula (I). The invention also provides the use of a compound of Formula (I) in the manufacture of a medicament for the treatment of a protozoan infection in a subject. The invention further provides a medical device when used in a method of treating or preventing a protozoan infection in a subject and to a medical device comprising the composition of the invention.Type: GrantFiled: June 4, 2020Date of Patent: November 10, 2020Assignee: NEOCULI PTY LTD.Inventors: Stephen Page, Andrew Stevens, Adam McCluskey, Martine Keenan, Rebecca Abraham
-
Publication number: 20200290990Abstract: The invention provides compounds of Formula (I), and their use in methods for treating or preventing a protozoan infection in a subject using a compound of Formula (I). The invention also provides the use of a compound of Formula (I) in the manufacture of a medicament for the treatment of a protozoan infection in a subject. The invention further provides a medical device when used in a method of treating or preventing a protozoan infection in a subject and to a medical device comprising the composition of the invention.Type: ApplicationFiled: June 4, 2020Publication date: September 17, 2020Inventors: Stephen Page, Andrew Stevens, Adam McCluskey, Martine Keenan, Rebecca Abraham
-
Patent number: 10752606Abstract: The invention provides compounds of Formula (I), and their use in methods for treating or preventing a protozoan infection in a subject using a compound of Formula (I). The invention also provides the use of a compound of Formula (I) in the manufacture of a medicament for the treatment of a protozoan infection in a subject. The invention further provides a medical device when used in a method of treating or preventing a protozoan infection in a subject and to a medical device comprising the composition of the invention.Type: GrantFiled: November 29, 2019Date of Patent: August 25, 2020Assignee: NEOCULI PTY LTD.Inventors: Stephen Page, Andrew Stevens, Adam McCluskey, Martine Keenan, Rebecca Abraham
-
Publication number: 20200102287Abstract: The invention provides compounds of Formula (I), and their use in methods for treating or preventing a protozoan infection in a subject using a compound of Formula (I). The invention also provides the use of a compound of Formula (I) in the manufacture of a medicament for the treatment of a protozoan infection in a subject. The invention further provides a medical device when used in a method of treating or preventing a protozoan infection in a subject and to a medical device comprising the composition of the invention.Type: ApplicationFiled: November 29, 2019Publication date: April 2, 2020Inventors: Stephen Page, Andrew Stevens, Adam McCluskey, Martine Keenan, Rebecca Abraham
-
Patent number: 10562880Abstract: The invention provides compounds of Formula (I), and their use in methods for treating or preventing a protozoan infection in a subject using a compound of Formula (I). The invention also provides the use of a compound of Formula (I) in the manufacture of a medicament for the treatment of a protozoan infection in a subject. The invention further provides a medical device when used in a method of treating or preventing a protozoan infection in a subject and to a medical device comprising the composition of the invention.Type: GrantFiled: July 8, 2019Date of Patent: February 18, 2020Assignee: NEOCULI PTY LTD.Inventors: Stephen Page, Andrew Stevens, Adam McCluskey, Martine Keenan, Rebecca Abraham
-
Publication number: 20190381175Abstract: The invention relates to a liquid formulation comprising propylene glycol and an effective amount of an inodilator, an angiotensin converting enzyme inhibitor, or a combination of an inodilator and an angiotensin converting enzyme inhibitor and to use of the formulation for treating cardiac disease and/or hypertension.Type: ApplicationFiled: August 16, 2019Publication date: December 19, 2019Inventors: Nicholas Bova, Stephen Page, Giuseppe Pippia
-
Publication number: 20190331392Abstract: Methods and apparatuses for transferring heat to and from multiple objects. Such a method entails placing objects in a vessel that contains a heat transfer fluid so that the objects contact the heat transfer fluid. The heat transfer fluid is at a temperature that is different from the temperature of the object, and is induced to circulate along a continuous flowpath. Each object is at least partially disposed in the flowpath of the heat transfer fluid, and each object is individually rotated about an axis of rotation thereof. The heat transfer fluid continues to circulate and the objects continue to rotate for a time sufficient to cause the temperatures of the objects to become closer to the heat transfer fluid temperature.Type: ApplicationFiled: April 26, 2019Publication date: October 31, 2019Inventors: Mitchell Anthony LoVerde, David Stephen Page, Kyle Chang Ma, Scott Robert Lancaster, Christopher James Mead
-
Publication number: 20190330178Abstract: The invention provides compounds of Formula (I), and their use in methods for treating or preventing a protozoan infection in a subject using a compound of Formula (I). The invention also provides the use of a compound of Formula (I) in the manufacture of a medicament for the treatment of a protozoan infection in a subject. The invention further provides a medical device when used in a method of treating or preventing a protozoan infection in a subject and to a medical device comprising the composition of the invention.Type: ApplicationFiled: July 8, 2019Publication date: October 31, 2019Inventors: Stephen Page, Andrew Stevens, Adam McCluskey, Martine Keenan, Rebecca Abraham
-
Patent number: 10413610Abstract: The invention relates to a liquid formulation comprising propylene glycol and an effective amount of an inodilator, an angiotensin converting enzyme inhibitor, or a combination of an inodilator and an angiotensin converting enzyme inhibitor and to use of the formulation for treating cardiac disease and/or hypertension.Type: GrantFiled: October 5, 2017Date of Patent: September 17, 2019Assignee: LUODA PHARMA LIMITEDInventors: Nicholas Bova, Stephen Page, Giuseppe Pippia
-
Patent number: 10392363Abstract: The invention provides compounds of Formula (I), and their use in methods for treating or preventing a protozoan infection in a subject using a compound of Formula (I). The invention also provides the use of a compound of Formula (I) in the manufacture of a medicament for the treatment of a protozoan infection in a subject. The invention further provides a medical device when used in a method of treating or preventing a protozoan infection in a subject and to a medical device comprising the composition of the invention.Type: GrantFiled: August 28, 2015Date of Patent: August 27, 2019Assignee: Neoculi Pty Ltd.Inventors: Stephen Page, Andrew Stevens, Adam McCluskey, Martine Keenan, Rebecca Abraham
-
Patent number: 10370341Abstract: The invention provides compounds of Formula I, and methods of treating or preventing a bacterial infection in a subject using a compound of Formula I. The invention also provides the use of a compound of Formula I in the manufacture of a medicament for the treatment of a bacterial infection in a subject. The invention further provides a medical device when used in a method of treating or preventing a bacterial infection in a subject and to a medical device comprising the composition of the invention.Type: GrantFiled: September 28, 2018Date of Patent: August 6, 2019Assignee: NEOCULI PTY LTDInventors: Stephen Page, Sanjay Garg, Martine Keenan, Adam McCluskey, Andrew Stevens
-
Patent number: 10253002Abstract: The invention provides compounds of Formula I, and methods of treating or preventing a bacterial infection in a subject using a compound of Formula I. The invention also provides the use of a compound of Formula I in the manufacture of a medicament for the treatment of a bacterial infection in a subject. The invention further provides a medical device when used in a method of treating or preventing a bacterial infection in a subject and to a medical device comprising the composition of the invention.Type: GrantFiled: May 1, 2014Date of Patent: April 9, 2019Assignee: NEOCULI PTY LTDInventors: Stephen Page, Sanjay Garg, Martine Keenan, Adam McCluskey, Andrew Stevens